Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07028398 · ClinicalTrials.gov registry record · NA

CMSL Ambulatory Sensitive Condition Nudge Study 2

A NA study of Behavioral Intervention and Emergency Department Visits, sponsored by Geisinger Clinic.

Recruiting
Registry status
NA
Development phase
12,990
Enrollment target
1
Study location

NCT07028398: Recruiting NA study of Behavioral Intervention and Emergency Department Visits, sponsored by Geisinger Clinic.

NCT07028398 is a NA study of Behavioral Intervention and Emergency Department Visits that is actively recruiting participants, run by Geisinger Clinic. The registered enrollment target is 12,990 participants, above the 1,177-participant average among 3 other Behavioral Intervention trials with a reported enrollment target (1004% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07028398, a NA study of Behavioral Intervention and Emergency Department Visits, is actively recruiting participants, sponsored by Geisinger Clinic.

RECRUITING
Registry status
NA
Development phase
12,990 participants
Enrollment target
1
Study location

Study Summary

The project aims to evaluate a nurse-led intervention to reduce inappropriate emergency department (ED) use among adult patients seen at Geisinger's Community Medicine Service Line (CMSL) clinics. The intervention occurs immediately following an appointment where a patient receives a diagnosis of an ambulatory sensitive condition (ASC; i.e., a condition considered to be a risk factor for near-term ED use). The evaluation will compare eligible patients with an ASC who were randomly assigned to receive follow-up outreach (patient portal message and/or call) from a nurse (who was automatically prompted via the Epic electronic health record system to initiate outreach) with those who were randomly assigned to receive standard care. Analyses will be intent-to-treat. The primary outcome is ED use in the week (i.e., 7 days) following the appointment. We ran an earlier version of this intervention (NCT06798389). The current study is modified based on results and clinical guidance. Specifically, more conditions will be included as qualifying ASCs for enrollment. Patients under 30 will be excluded. And rather than calling all patients as in the original study, patient portal users may be contacted via the portal instead of or in addition to a phone call. Finally, in the first study, the intervention was differentially effective by age group (\<45, 45-64, 65+). Our primary analysis will be conducted separately by age group, though we will also conduct an analysis combining across age groups. We will run the study until we reach at least 4,330 patients in each of the following age groups: patients aged 30-45, patients aged 45-64, patients aged 65+. Therefore, our estimated sample size is at least 4,330x3 = 12,990. We may be required to do an interim data pull and/or stop the study early at the direction of clinical or operational leaders.

Primary Outcome

Visited the ED (y/n)

Interventions

  • BEHAVIORAL Nurse Nudge

Study Locations (1)

Pennsylvania

  • Geisinger - Danville

Trial Details

FieldValue
Enrollment Target 12,990 participants
Start Date 2025-05-29
Est. Completion 2026-07-31
Phase NA
Geisinger Clinic

107 total trials

What NCT07028398 shows while recruiting

NCT07028398 is an interventional study that assigns participants to a tested intervention. Its 12,990 participants enrollment target places it among the larger protocols in the corpus, above the 1,177-participant average among 3 other Behavioral Intervention trials with a reported enrollment target (1004% higher).

The record links to 3 conditions, with Behavioral Intervention appearing as the primary indexed condition, and to 1 intervention - of which Nurse Nudge is the first listed.

NCT07028398 reports a single indexed study location in Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT07028398 about?

NCT07028398 is a clinical study titled "CMSL Ambulatory Sensitive Condition Nudge Study 2". The project aims to evaluate a nurse-led intervention to reduce inappropriate emergency department (ED) use among adult patients seen at Geisinger's Community Medicine Service Line (CMSL) clinics. The intervention occurs immediately following an appointment where a patient receives a diagnosis of an...

What is the current status of trial NCT07028398?

This trial is currently recruiting. It is a NA study. The enrollment target is 12,990 participants. The study started on 2025-05-29. Estimated completion is 2026-07-31.

What conditions does trial NCT07028398 study?

This clinical trial studies the following conditions: Behavioral Intervention, Emergency Department Visits, Nurse Care Coordination.

What interventions are being tested in trial NCT07028398?

The interventions under investigation include: Nurse Nudge (BEHAVIORAL).

Who is sponsoring clinical trial NCT07028398?

This trial is sponsored by Geisinger Clinic, which has 107 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07028398 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Behavioral Intervention

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05991453 · 13,000 participants · NA

    Trajectories of Recovery After Intravenous Propofol Versus Inhaled VolatilE Anesthesia Trial

  • NCT07177352 · 13,000 participants · Phase 3

    Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies

  • NCT03586895 · 12,838 participants · NA

    e-Connect: A Service System Intervention for Justice Youth at Risk for Suicide

  • NCT07037433 · 12,800 participants · Phase 3

    Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT07028398, the US trial registry maintained by the National Library of Medicine. NCT07028398 (large enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.